
First Patient Receives Stem-Cell Transplant for Parkinson's in Japan
Japanese drugmaker Sumitomo Pharma says the first patient has been treated with iPS cell-derived brain cell precursors for Parkinson's disease, after the therapy won conditional approval in March.













